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license (http://creativethrough biomarker pathways such as amyloid-b (Ab); however, few studies have investigated dietary/
Ab relationships, and no study has investigated this relationship in women.
Methods: Dietary patternswere extrapolated for 115 participants from theWomen’sHealthAgingProj-
ect. Ab deposition was measured via in vivo F-18 florbetaben positron emission tomography scanning.
Results: Participants were, on average, aged 70 years (62.63 SD), had 13 years of education (63.57
SD), a BMI of 28 kg/m2 (65.46 SD), and a daily energy intake of 5161 kJ (61679.03 SD). Four di-
etary patterns were identified: high fat, Mediterranean, junk food, and low fat. Adherence to the junk
food diet was a significant predictor of Ab deposition (b 5 .10, P 5 .03).
Discussion: This study highlights the potential of diet to influence neurodegenerative disease and as
a potential modifiable lifestyle risk factor for Alzheimer’s disease.
 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Diet may play a substantial role in the Alzheimer’s dis-
ease (AD) symptomatology and offer great potential for non-
pharmacological prevention. Epidemiological evidence has
suggested increased adherence to a Mediterranean diet [1],
low glycemic index [2,3], and higher consumption of
omega-3 polyunsaturated fatty acids [4] were associated
with a decrease in AD biomarker burden. Systematic review
found 50 out of 64 studies revealed an association between
diet and AD incidence [5]; however, only one study has
used a priori analysis to analyze dietary associations with
the hallmark cerebral protein implicated in AD, b-amyloidthor. Tel.:1 61 3 8344 1835; Fax:161 3 9347 1863.
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commons.org/licenses/by-nc-nd/4.0/).(Ab). In this study, dietary pattern analysis identified a
pattern characterized by a higher intake of fresh fruit, vege-
tables, whole grains, fish, and low-fat dairies, and a lower
intake of sweets, fried potatoes, processed meat, and butter
was negatively associated with in vivo cerebral Ab [6].
Furthermore, male and mixed cohort studies predominate
the research, and to date, no study has investigated this rela-
tionship specifically in women. Women are more likely than
men to develop AD [7], have a higher penetrance for the
apolipoprotein ε-4 (APOE-ε4) allele [8], and are more likely
to progress from mild cognitive impairment to AD [8]. Im-
pacts of higher male mortality, vascular risk factors, and
the postmenopausal loss of estrogenic neuroprotection sug-
gest females are 1.5 times more likely to develop AD than
men [9]. Given sex differences in AD risk, research is needed
for those at greater risk of disease.imer’s Association. This is an open access article under the CC BY-NC-ND
Table 1
Food groupings from Dietary Questionnaire for Epidemiological Studies
Version 2 (DQES v2)
Food group Items in the DQES v2
Whole grains All bran, bran flakes, high fiber white
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to clarify how nutrition promotes healthy brain aging and
to identify neuroprotective patterns for those at the greatest
risk of AD. The objectives of this study were to identify di-
etary patterns using an a priori approach and investigate
their associations with Ab deposition in healthy aging
Australian women. We previously reported on a lack of a
relationship between a healthy Mediterranean diet and Ab
deposition [10] and hypothesized this was due to limitations
of the self-reported food frequency questionnaire in
measuring the potentially beneficial phytochemicals in olive
oil. Given high-fat, high-glycemic diets have been associ-
ated with increased AD biomarker burden, we hypothesized
that a dietary pattern characterized by high-fat, high-sugar
content would be associated with an increase in cerebral
Ab pathology.bread, muesli, multigrain bread,
porridge, rye bread, Weet-Bix,
wholemeal bread
Refined grains Corn flakes, crackers, pasta, rice,
white bread
Red meats Beef, lamb, pork, veal
Processed meats Bacon, salami, sausages
Poultry Chicken
Takeaway foods Hamburger, meat pies, pizza
Fried fish Fried fish
Other fish Fish (nonfried), tinned fish
Fried potatoes Chips (French fries)
Other potato Potatoes
Yellow or red vegetables Capsicum, carrots, pumpkin
Legumes Baked beans, green beans, other
beans, peas, tofu
Cruciferous vegetables Broccoli, cabbage, cauliflower
Leafy green vegetables Lettuce, spinach
Other vegetables Bean sprouts, beetroot, celery,
cucumber, garlic, mushrooms,
onion, zucchini
Tomato Tomatoes
Fresh fruit Apples, apricots, avocado, bananas,
mango, melon, oranges, peaches,
pears, pineapple, strawberries
Canned fruit Tinned fruit
Cakes, biscuits, sweet pastries Cakes, sweet biscuits
Low-fat dairy products Flavored milk drink, low-fat cheese,
reduced fat milk, ricotta cheese,
cottage cheese, skim milk
Full-fat dairy products Cream cheese, firm cheese, full-
cream milk, hard cheese, ice
cream, soft cheese, yoghurt
Soya milk Soya milk
Confectionery Chocolate
Added sugar Jam, sugar
Crisps Crisps
Nuts Nuts, peanut butter
Eggs Eggs
Fruit juice Fruit juice
Saturated spreads Butter, butter-margarine blends,
margarine
Unsaturated spreads Monounsaturated margarine,
polyunsaturated margarine
Alcohol–beer Heavy beer, light beer
Alcohol–wine Red wine, white wine
Alcohol–spirits Fortified wines, spirits2. Methods
2.1. Study population
Participants were sought from the 2012 follow-up of the
Women’s Health Ageing Project (WHAP), an epidemiolog-
ically sourced prospective study of healthy aging Australian
women. WHAP is an extension of the Melbourne Women’s
Midlife Health Project. Briefly, 438 women within the Mel-
bourne metropolitan area were identified by random digit
dialing in 1991. Women were eligible for the cohort if they
were Australian-born, aged 45–55 years, had menstruated
in the three months before recruitment, and were not taking
estrogen-containing hormone replacement therapy. In 2012,
participants were re-contacted and invited to participate in a
late-life health study. Clinical assessments were conducted
on 252 participants by trained field researchers. The clinical
assessments included a battery of validated measures of
physical health, sociodemographics, lifestyle, cognitive
function, psychological health, and biomarkers. A complete
methodology has been published elsewhere [11].
2.2. Diet
Participants completed a validated food frequency ques-
tionnaire entitled the Dietary Questionnaire for Epidemio-
logical Studies Version 2 (DQES v2) [12]. The DQES v2
incorporates 80 food items with frequency response options
on 74 of these items. The DQES v2 covers five types of di-
etary intake: cereals/sweets/snacks, dairy/meat/fish, fruits,
vegetables, and alcoholic beverages. Data collected by
the DQES v2 was used to calculate daily energy and
nutrient intakes by the Cancer Council of Victoria based
on Australian nutrient composition data from NUTTAB95,
collated via the Composition of Foods, Australia [13]. In-
dividuals were removed if their energy intake was reported
as below 3000 kJ/day or above 20,000 kJ/day. All food
items were reported in grams per day and placed into 33
food groups defined a priori (Table 1) that was similar to
those used by others [14,15]. Dietary patterns wereextrapolated from food groupings using iterated principal
factor analysis with oblique varimax rotation due to the
presumed intercollinearity and nonindependence of
dietary patterns.2.3. Imaging
In the 2012 follow-up, all WHAP participants were
offered the opportunity to have cerebral imaging. Ab depo-
sition was measured via in vivo F-18 Florbetaben positron
Table 2
Dietary pattern factor loadings for all WHAP participants in 2012 (n5 224)
Variable High fat Mediterranean
Junk
food
Low
fat
Eigenvalue 3.03802 2.13623 1.80738 1.55595
Variance 2.15252 2.00648 1.58108 1.39511
Proportion 0.3164 0.2949 0.2324 0.2051
Whole grains 0.3668 0.2096 0.1387
Refined grains 0.1598 0.1673 0.1247
Red meats 0.5464 0.1128
Processed meats 0.7281
Poultry 0.4130 0.1302 0.1549
Takeaway foods 0.2021 20.2543 0.3427
Fried fish 0.4662 0.2473
Other fish 0.4029 0.3867
Fried potatoes 0.4195
Other potato 0.1803 0.1127 0.3143
Yellow or red vegetables 0.1675 0.2594 0.1480 0.5034
Legumes 0.2923 0.3134
Cruciferous vegetables 0.2117 20.1027 0.4114
Leafy green vegetables 0.5466
Other vegetables 0.1961 0.6869 0.1286
Tomato 20.2459 0.2255
Fresh fruit 20.2786 0.3381 0.1887
Canned fruit 0.1337
Cakes, biscuits,
sweet pastries
0.6350
Low-fat dairy products 20.2222 0.5117
Full-fat dairy products 0.1754 0.1255 20.4775
Soya milk 0.1843 20.1101
Confectionery 20.1195 0.2484 0.5211
Added sugar 0.1263 0.4327
Crisps 0.1405 0.1229
Nuts 0.4485 0.1703
Eggs 0.1083 0.1448
Fruit juice 20.1134
Saturated spreads 20.2113
Unsaturated spreads 0.2165
Alcohol–beer 0.1540 20.1618 20.1272
Alcohol–wine 0.1345 0.1586 20.2868
Rotated factor loadings for iterated principal factor analysis with oblique
promax rotation. Blanks represent absent loadings (,0.1). Alcohol–spirits
not shown due to not loading (.0.1) on any factor.
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PET in Victoria, Australia. Participants received 250MBq of
18F-florbetaben intravenously, with a 20-minute acquisition
commencing 90 minutes after injection. Standardized up-
take values (SUVs) were calculated for all brain regions
examined, and standard uptake value ratios (SUVRs) were
generated by normalizing regional SUVs by the cerebellar
cortex with atrophy correction from structural magnetic
resonance imaging. Neocortical SUVR, a global index of
Ab burden, is expressed as the average SUVR of the area-
weighted mean. Area-weighted means were calculated for
each participant by averaging the frontal, superior parietal,
lateral temporal, lateral occipital, and anterior and posterior
cingulate regions. This protocol has been described else-
where [11].
2.4. Covariates
Age (in years), education (in years), and body mass index
(BMI) were collected as part of the clinical assessments in
2012. Total energy intake in kilojoules was calculated by
the Cancer Council of Victoria from the DQES v2. The Con-
sortium to Establish a Registry for Alzheimer’s Disease (CE-
RAD) Savings Score was used as a valid indicator of
cognitive ability [16]—it has been suggested as the most
reliable index in differentiating cognitively normal individ-
uals from AD [17]. Participants’ APOE genotype was deter-
mined by direct sequencing and were dichotomized as an
APOE ε4 carrier (APOE ε2/ε4, APOE ε3/ε4, and APOE
ε4/ε4) or a noncarrier. Adherence to identified dietary pat-
terns was converted from weighted factor loadings to binary
adherence to minimize the intracorrelations between vari-
ables. All analyses were adjusted for age in years, education
in years, energy intake (kJ/day), cognition (CERAD Sav-
ings), and binary presence of the APOE ε4 allele.
2.5. Statistical analysis
All analyses were conducted in STATA software on Win-
dows operating system. Complete data were available for
115WHAP participants, and there were no significant differ-
ences between the included (n 5 115) and excluded
(n 5 137) cohorts. PET SUVRs displayed a positive skew
that was rectified using 1/square transformation; therefore,
results should be interpreted as inverse coefficient deriva-
tives. Generalized linear models were used to assess associ-
ations between Ab deposition and dietary patterns scores.
Generalized linear models were adjusted for age in years, ed-
ucation in years, cognition (CERAD Savings), and binary
presence of the APOE ε4 allele.3. Results
Four dietary patterns were identified: high fat, Mediterra-
nean, junk food, and low fat. Factor loadings (Table 2 and
Fig. 1) indicated that the high-fat diet loaded heavily on
food groups such as processed meats, fried fish, red meats,fried potatoes, and poultry. The Mediterranean style diet
loaded chiefly on whole grains, vegetables, nuts, fish, and
wine as the main source of alcohol. The unhealthy junk food
pattern was characterized by high consumption of takeaway
foods, added sugar, confectionary and cakes, biscuits, and
sweet pastries, whereas the low-fat diet loaded heavily on
low-fat dairy products, vegetables, and unsaturated spreads.
Participants’ characteristics are found in Table 3. Partici-
pants in the Mediterranean diet group (n 5 31) displayed
the highest level of education (14.10 6 3.87 years), highest
CERAD Savings score (72.97 6 31.07), and lowest level of
Ab deposition (PET SUVR 1.0834 6 0.14). Daily energy
intake was highest in the high-fat group (5443.46
6 2116.50 kJ/day) and lowest in the Mediterranean group
(4677.26 6 1242.79 kJ/day). Significant group differences
were observed in education, energy intake, and CERAD
Fig. 1. Spider diagram of factor loadings by dietary patterns.
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linear models.
Adherence to the junk food diet (Table 4) was a signifi-
cant predictor of Ab deposition (b 5 .10, P 5 .036) as
was binary presence of the APOE ε4 allele (b 5 .11,
P 5 .004). No significant interaction effects were observed
in the combined effect of diet and APOE ε4 on Ab deposi-
tion (P5 .59). All other dietary patterns were not associated
with Ab deposition. Age, education, and cognition were also
not significantly associated with Ab deposition.4. Discussion
In this cross-sectional study in Australian women, adher-
ence to the junk food was a significant predictor of cerebral
Ab deposition. These results suggest that higher adherence
to a high-fat, high-sugar style diet may be associated with
an increased deposition of AD biomarkers and a higher
risk for disease.
We observed similar cognitive status between dietary
groups. However, women adhering to the Mediterranean di-
etary pattern displayed significantly higher cognitive scoresthan the other dietary groups. In the longitudinal Nurse’s
Health Study, women with higher Mediterranean diet adher-
ence had significantly higher overall cognitive status [18].
Given evidence for the cardiovascular determinants of
cognitive decline [19,20], there is clear evidence for an
inverse relationship between Mediterranean diet adherence
and cognition; however, the cross-sectional nature of this
study limits our ability to address this relationship.
Our results contribute to the growing body of evidence
linking diet with AD. A high-glycemic diet has been associ-
ated with greater amyloid burden in the brain [2] and cere-
brospinal fluid measures [3,21,22]. A principal component
analysis on nutrient intake patterns showed consumption
of omega-3 fatty acids, zinc, vitamin B-12, and vitamin D
was associated with decreased amyloid deposition [6,23].
Consumption of omega-3 fatty acid supplementation has
been shown to be related to tau (phosphorylated and total)
and amyloid biomarkers of AD in cerebrospinal fluid [24].
Serum docosahexaenoic acid has also been inversely associ-
ated with cerebral amyloid burden [25].
Research has established that diets with higher consump-
tion of sugar, carbohydrates, and high-glycemic foods are
Table 3
Descriptive statistics for the included participants grouped by adherence to dietary patterns identified using IPFA
Variable High fat (n 5 24) Mediterranean (n 5 31) Junk food (n 5 24) Low fat (n 5 35) Total (n 5 115)
Age (in years) 69.79 6 2.42 69.45 6 2.23 70.41 6 3.19 69.57 6 2.70 69.76 6 2.63
Education (in years) 12.88 6 3.67 14.10 6 3.87 11.50 6 2.96 12.63 6 3.36 12.84 6 3.57
BMI 28.58 6 6.75 27.43 6 5.48 27.14 6 5.58 29.29 6 4.26 28.18 6 5.46
Energy (kJ/day) 5443.46 6 2116.50 4809.79 6 1145.51 6035.40 6 1993.21 4677.26 6 1242.79 5160.53 6 1679.03
APOE positive, n (%) 9 (37.5) 9 (29.0) 9 (37.5) 10 (28.57) 37 (32.46)
CERAD Savings Score (%) 72.93 6 18.08 72.97 6 31.07 65.57 6 28.76 63.34 6 28.62 68.45 6 27.52
PET SUVR (raw) 1.1296 6 0.1539 1.0835 6 0.1427 1.2150 6 0.2458 1.1300 6 0.2336 1.1352 6 0.2026
PET SUVR (transformed) 0.8185 6 0.1770 0.8829 6 0.1646 0.7389 6 0.2174 0.8446 6 0.2043 0.8273 6 0.1959
Abbreviations: APOE, apolipoprotein E; BMI, body mass index; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; PET, positron emis-
sion tomography; SUVR, standard uptake value ratio.
NOTE. If not otherwise described, data are presented as mean 6 standard deviation of the mean.
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glucose metabolism affects the production and clearance of
Ab and tau phosphorylation [27], and both insulin resistance
[28] and type-2 diabetes [29] are risk factors for AD. Several
animal studies have illustrated that a high-fat diet causes
brain Ab accumulation in wild-type rabbits [30] and trans-
genic mice [31,32]. Furthermore, human APOE isoforms
have been shown to modulate glucose and metabolic
pathways, with the APOE ε3/ε4 variants showing markedly
reduced glucose uptake and metabolism in mouse models
[33]. APOE ε2 brains demonstrated a more robust metabolic
profile than APOE ε3/ε4, suggesting a physiological mecha-
nism for its protective role against AD [33].
We speculate that the relationship observed between a high-
fat, high-sugar diet and increased cerebral Ab deposition may
be modulated by impaired glucose metabolism in this female-
only cohort. We believe our results suggest an impaired
glucose metabolic pathway interacting with an APOE-Ab
physiological mechanism. Research has been shown that
APOE ε4 confers a greater risk in women than men [8].
Women with a single APOE ε4 allele have up to a four-fold in-Table 4
Generalized linear model for independent variables (PET SUVR) and four
dietary patterns identified using iterative principal factor analysis. (95% CIs
shown; n 5 114)
PET SUVR Coefficient Std. Err. P CI lower CI higher
High fat 20.00705 0.04372 .872 20.09273 0.07864
Mediterranean 0.06390 0.04349 .142 20.02135 0.14915
Junk food 20.09740 0.04511 .031 20.18582 20.00898
Low fat 0.02338 0.03962 .555 20.05428 0.10103
Age (in years) 20.00120 0.00702 .864 20.01495 0.01256
Education (in years) 0.00139 0.00502 .781 20.00845 0.01125
BMI 20.00076 0.00326 .816 20.00714 0.00563
Energy (kJ/day) 20.00001 0.00001 .309 20.00003 0.00001
APOE Presence 20.10916 0.03919 .005 20.18598 20.03233
CERAD Savings Score 0.00125 0.00065 .054 20.00002 0.00252
Abbreviations: APOE, apolipoprotein E; BMI, body mass index; CE-
RAD, Consortium to Establish a Registry for Alzheimer’s Disease; CI, con-
fidence interval; PET, positron emission tomography; SUVR, standard
uptake value ratio.
NOTE. Bold indicates statistical significance (P, .05). CIs are for coef-
ficient. Analysis adjusted for age in years, education in years, cognition (CE-
RAD Savings score), and binary presence of the APOE ε4 allele.crease in risk when compared with women homozygous for
APOE ε3; however, men with a single APOE ε4 allele have lit-
tle to no increase in risk [34]. Given animal model evidence for
an APOE-mediated glucose metabolism [33], females may
experience greater AD risk due to a mechanistic action in their
glucose metabolism. Further research is required to elucidate
the physiological mechanisms that underpin this relationship,
for example, to replicate animal evidence of glucose meta-
bolism in human models of APOE ε4 isoforms.
Our findings strengthen the hypothesis of diet being a
modifiable risk factor for AD by linking amyloid deposition
with an unhealthy-type diet in a female-only cohort. These
findings suggest a metabolic pathway linking diet with cere-
bral Ab deposition and should motivate investigations into
dietary impacts on glucose metabolism by variations in pres-
ence of the APOE ε2/ε3/ε4 alleles.Acknowledgments
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1. Systematic review: The authors previously conduct-
ed a systematic review that highlighted the paucity
of research regarding dietary adherence and bio-
markers of Alzheimer’s disease. This review was
conducted in accordance with PRISMA guidelines
(PROSPERO: CRD42017076389) searching MED-
LINE, PubMed, PsycINFO, Google Scholar, and
SCOPUS databases.
2. Interpretation: Our findings contribute to the growing
body of evidence linking diet with Alzheimer’s dis-
ease. We speculate that the relationship observed be-
tween a high-fat, high-sugar diet and increased
cerebral b-amyloid deposition is affected by
impaired glucose metabolism. These findings sug-
gest an apolipoprotein E (APOE)–mediated glucose
metabolic pathway.
3. Future directions: Our research suggests a metabolic
pathway linking diet with cerebral Ab deposition and
should motivate investigations into dietary impacts
on glucose metabolism and Alzheimer’s disease
biomarker deposition by variations in presence of
the APOE ε2/ε3/ε4 alleles.References
[1] Merrill DA, Siddarth P, Raji CA, Emerson ND, Rueda F, Ercoli LM,
et al. Modifiable risk factors and brain positron emission tomography
measures of amyloid and tau in nondemented adults with memory
complaints. Am J Geriatr Psychiatry 2016;24:729–37.[2] Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK,
Mahnken JD, et al. A high-glycemic diet is associated with cerebral
amyloid burden in cognitively normal older adults. Am J Clin Nutr
2017;106:1463–70.
[3] Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD,
Watson GS, et al. Diet intervention and cerebrospinal fluid biomarkers
in amnestic mild cognitive impairment. Arch Neurol 2011;68:743–52.
[4] Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N. Nutrient
intake and plasma beta-amyloid. Neurology 2012;78:1832–40.
[5] Yusufov M, Weyandt LL, Piryatinsky I. Alzheimer’s disease and diet:
A systematic review. Int J Neurosci 2017;127:161–75.
[6] Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, et al. Nutrient
patterns and brain biomarkers of Alzheimer’s disease in cognitively
normal individuals. J Nutr Health Aging 2015;19:413–23.
[7] Pike KE, Ellis KA, Villemagne VL, Good N, Chetelat G, Ames D,
et al. Cognition and beta-amyloid in preclinical Alzheimer’s disease:
Data from the AIBL study. Neuropsychologia 2011;49:2384–90.
[8] Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the
APOE-related risk of developing Alzheimer disease. Ann Neurol
2014;75:563–73.
[9] Vi~na J, Lloret A. Why women have more Alzheimer’s disease than
men: Gender and mitochondrial toxicity of amyloid-b peptide. J Alz-
heimer’s Dis 2010;20:527–33.
[10] Hill E, Szoeke C, Dennerstein L, Campbell S, Clifton P. Adherence to
the Mediterranean Diet is not Related to Beta-Amyloid Deposition:
Data from the Women’s Healthy Ageing Project. J Prev Alzheimers
Dis 2018;5:137–41.
[11] Szoeke C, Coulson M, Campbell S, Dennerstein L. Cohort profile:
Women’s Healthy Ageing Project (WHAP): A longitudinal prospective
study ofAustralian women since 1990.Women’sMidlifeHeal 2016;2:5.
[12] Giles GG, Ireland PD. Dietary Questionnaire for Epidemiological Studies
(Version 2). Melbourne, Australia: The Cancer Council of Victoria; 1996.
[13] Thomas S, CordenM.Metric Tables of Composition of Australian Foods.
Canberra, Australia: Australian Government Publishing Service; 1977.
[14] AmbrosiniGL, Fritschi L,DeKlerkNH,MackerrasD, Leavy J.Dietary
patterns identified using factor analysis and prostate cancer risk: A case
control study in Western Australia. Ann Epidemiol 2008;18:364–70.
[15] Ambrosini GL, Oddy WH, Robinson M, O’Sullivan TA, Hands BP, De
Klerk NH, et al. Adolescent dietary patterns are associated with lifestyle
and family psycho-social factors. Public Health Nutr 2009;12:1807–15.
[16] Lamberty GJ, Kennedy CM, Flashman LA. Clinical utility of the CE-
RAD word list memory test. Appl Neuropsychol 1995;2:170.
[17] Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G,
et al. The Consortium to Establish a Registry for Alzheimer’s Disease
(CERAD). Part V. A normative study of the neuropsychological bat-
tery. Neurology 1994;44:609–14.
[18] Samieri C, Okereke OI, Devore E, Grodstein F. Long-term adherence
to the mediterranean diet is associated with overall cognitive status,
but not cognitive decline, in women. J Nutr 2013;143:493–9.
[19] Grodstein F. Cardiovascular risk factors and cognitive function. Alz-
heimers Dement 2007;3:S16–22.
[20] Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives
regarding late-life dementia. Nat Rev Neurol 2009;5:649.
[21] Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW,
Baker LD, et al. Effect of apolipoprotein E genotype and diet on apoli-
poprotein E lipidation and amyloid peptides: Randomized clinical
trial. JAMA Neurol 2013;70:972–80.
[22] Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA,
Callaghan M, et al. High-intensity physical activity modulates diet ef-
fects on cerebrospinal amyloid-b levels in normal aging and mild
cognitive impairment. J Alzheimer’s Dis 2012;28:137–46.
[23] Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N,
et al. Nutrient intake and brain biomarkers of Alzheimer’s disease in
at-risk cognitively normal individuals: A cross-sectional neuroimag-
ing pilot study. BMJ Open 2014;4:e004850.
[24] Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxen Irving G,
Eriksdotter M, et al. Transfer of omega-3 fatty acids across the
E. Hill et al. / Alzheimer’s & Dementia: Translational Research & Clinical Interventions 4 (2018) 535-541 541blood-brain barrier after dietary supplementation with a docosahexae-
noic acid-rich omega-3 fatty acid preparation in patients with Alz-
heimer’s disease: The OmegAD study. J Int Med 2014;275:428–36.
[25] Yassine HN, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN,
et al. Association of serum docosahexaenoic acid with cerebral
amyloidosis. JAMA Neurol 2016;73:1208–16.
[26] Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and
health—a systematic review and meta-analysis: Relations between di-
etary glycemic properties and health outcomes–. Am J Clin Nutr 2008;
87:258S–68.
[27] Sato N, Morishita R. The roles of lipid and glucose metabolism in
modulation of b-amyloid, tau, and neurodegeneration in the pathogen-
esis of Alzheimer disease. Front Aging Neurosci 2015;7:199.
[28] Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al.
Insulin resistance is associated with the pathology of Alzheimer dis-
ease The Hisayama Study. Neurology 2010;75:764–70.
[29] Huang C-C, Chung C-M, Leu H-B, Lin L-Y, Chiu C-C, Hsu C-Y, et al.
Diabetes mellitus and the risk of Alzheimer’s disease: A nationwide
population-based study. PLoS One 2014;9:e87095.[30] Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T, Gross DR.
Induction of Alzheimer-like b-amyloid immunoreactivity in the brains
of rabbits with dietary cholesterol. Exp Neurol 1994;126:88–94.
[31] Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-
Thomas T, Wang R, et al. Hypercholesterolemia accelerates the Alz-
heimer’s amyloid pathology in a transgenic mouse model. Neurobiol
Dis 2000;7:321–31.
[32] Ho L, QinW, Pompl PN, Xiang Z, Wang J, Zhao Z, et al. Diet-induced
insulin resistance promotes amyloidosis in a transgenic mouse model
of Alzheimer’s disease. FASEB J 2004;18:902–4.
[33] Keeney JT-R, Ibrahimi S, Zhao L. Human ApoE isoforms differen-
tially modulate glucose and amyloid metabolic pathways in female
brain: Evidence of the mechanism of neuroprotection by ApoE2 and
implications for Alzheimer’s disease prevention and early interven-
tion. J Alzheimer’s Dis 2015;48:411–24.
[34] Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R,
et al. Effects of age, sex, and ethnicity on the association between
apolipoprotein E genotype and Alzheimer disease - A meta-analysis.
JAMA 1997;278:1349–56.
